Kenneth Pienta - Net Worth and Insider Trading
Kenneth Pienta Net Worth
The estimated net worth of Kenneth Pienta is at least $4,601 dollars as of 2024-11-13. Kenneth Pienta is the Chief Medical Officer of Cue Biopharma Inc and owns about 2,000 shares of Cue Biopharma Inc (CUE) stock worth over $3,380. Kenneth Pienta is also the Director of Curis Inc and owns about 300 shares of Curis Inc (CRIS) stock worth over $1,221. Details can be seen in Kenneth Pienta's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Kenneth Pienta has not made any transactions after 2021-03-16 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Kenneth Pienta
Kenneth Pienta Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Kenneth Pienta owns 2 companies in total, including Cue Biopharma Inc (CUE) , and Curis Inc (CRIS) .
Click here to see the complete history of Kenneth Pienta’s form 4 insider trades.
Insider Ownership Summary of Kenneth Pienta
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| CUE | Cue Biopharma Inc | 2021-03-16 | Chief Medical Officer |
| CRIS | Curis Inc | 2013-11-08 | director |
Kenneth Pienta Latest Holdings Summary
Kenneth Pienta currently owns a total of 2 stocks. Among these stocks, Kenneth Pienta owns 2,000 shares of Cue Biopharma Inc (CUE) as of March 16, 2021, with a value of $3,380 and a weighting of 73.46%. Kenneth Pienta also owns 300 shares of Curis Inc (CRIS) as of November 8, 2013, with a value of $1,221 and a weighting of 26.54%.
Latest Holdings of Kenneth Pienta
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| CUE | Cue Biopharma Inc | 2021-03-16 | 2,000 | 1.69 | 3,380 |
| CRIS | Curis Inc | 2013-11-08 | 300 | 4.07 | 1,221 |
Holding Weightings of Kenneth Pienta
Kenneth Pienta Form 4 Trading Tracker
According to the SEC Form 4 filings, Kenneth Pienta has made a total of 4 transactions in Cue Biopharma Inc (CUE) over the past 5 years, including 1 buys and 3 sells. The most-recent trade in Cue Biopharma Inc is the sale of 13,439 shares on March 16, 2021, which brought Kenneth Pienta around $202,929.
According to the SEC Form 4 filings, Kenneth Pienta has made a total of 0 transactions in Curis Inc (CRIS) over the past 5 years. The most-recent trade in Curis Inc is the acquisition of 200 shares on November 8, 2013, which cost Kenneth Pienta around $59,000.
Insider Trading History of Kenneth Pienta
- 1
Kenneth Pienta Trading Performance
GuruFocus tracks the stock performance after each of Kenneth Pienta's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Kenneth Pienta is -16.77%. GuruFocus also compares Kenneth Pienta's trading performance to market benchmark return within the same time period. The performance of stocks bought by Kenneth Pienta within 3 months outperforms 1 times out of 3 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Kenneth Pienta's insider trading performs compared to the benchmark.
Performance of Kenneth Pienta
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 6.92 | | | | | |
| Relative Return to S&P 500(%) | 5.33 | | | | | |
Kenneth Pienta Ownership Network
Ownership Network List of Kenneth Pienta
Ownership Network Relation of Kenneth Pienta
Kenneth Pienta Owned Company Details
What does Cue Biopharma Inc do?
Who are the key executives at Cue Biopharma Inc?
Kenneth Pienta is the Chief Medical Officer of Cue Biopharma Inc. Other key executives at Cue Biopharma Inc include President and CSO Anish Suri , director & CEO Daniel R Passeri , and Chief Medical Officer Matteo Levisetti .
Cue Biopharma Inc (CUE) Insider Trades Summary
Over the past 18 months, Kenneth Pienta made no insider transaction in Cue Biopharma Inc (CUE). Other recent insider transactions involving Cue Biopharma Inc (CUE) include a net purchase of 4,000 shares made by Anish Suri , and a net purchase of 3,000 shares made by Daniel R Passeri .
In summary, during the past 3 months, insiders sold 0 shares of Cue Biopharma Inc (CUE) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Cue Biopharma Inc (CUE) were sold and 7,000 shares were bought by its insiders, resulting in a net purchase of 7,000 shares.
Cue Biopharma Inc (CUE)'s detailed insider trading history can be found in Insider Trading Tracker table.
Cue Biopharma Inc Insider Transactions
Kenneth Pienta Mailing Address
Above is the net worth, insider trading, and ownership report for Kenneth Pienta. You might contact Kenneth Pienta via mailing address: C/o Curis, Inc., 4 Maguire Road, Lexington Ma 02421.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
